In October 2020, the AIT will start hosting remote meetings using Cisco WebEx.
Attending the webinars is free, however, with limited spaces, registration in advance is essential. Once spaces are filled you will be added to a reserve list (you will be notified if you have been successful or if you are placed on the reserve list). Details on how to register for each of the Webinar sessions will be sent out soon.
At the current time the AIT are unsure if the presentations will be recorded for future viewing.
Webinar 1: Tuesday 13th October 2020 – 50 minutes commencing at 13:00 GMT
Inhalation Delivery and SARS Preclinical Models - presented by J. McDonald (Lovelace Biomedical).
Webinar 2: Thursday 15th October 2020 – 50 minutes commencing at 13:00 GMT
Early De-risking Approaches for Identification of Anti-Fibrotics for Idiopathic Pulmonary Fibrosis (IPF) Treatment - presented by C. Roper, M. McElroy and J. Aarbiou (Charles River Laboratories).
Webinar 3: Tuesday 20th October 2020 – 50 minutes commencing 13:00 GMT
Phase I: The transition from nonclinical to clinical and beyond - presented by C. Laing (Covance).
Webinar 4: Thursday 22nd October 2020 – 50 minutes commencing at 13:00 GMT
Regulatory Toxicology: Safety Margin Assessments of Inhalation Drug Products - presented by D. Jones (MHRA, UK) and L. Pei (FDA, US).
The details for joining the WebEx meetings will be sent out to each registered person approximately 1 week prior to each presentation. Unfortunately the link sent to you to join the WebEx cannot be shared with other people (as numbers to attend are limited only registered delegates will be able to attend).
Hopefully many of our AIT associates will be able to attend these interesting Webinar sessions.
Visit - https://www.aitoxicology.org/ for more information.